Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension - BENEFiT

Description:

The goal of the trial was to evaluate the oral endothelin receptor antagonist bosentan in patients with chronic thromboembolic pulmonary hypertension (CTEPH).